PharmaCheckSA

Corruption in the Pharmaceutical Trade BAYER AG As an opener to this article that describes very directly what the corporate world of pharmaceuticals is about, I would like to quote Marijn Dekkers, CEO of Bayer AG, December 3, 2013 – “We did not develop this medicine for Indians. We developed it for Western patients who can afford it.” The original Businessweek article has been removed from the internet, including its internet cache and the video that was on ft-live.com . https://www.keionline.org/node/1924 , http://www.dailymail.co.uk/news/article-2545360/Pharmaceutical-chief-tries-stop-India-replicating-cancer-treatment.html Bayer AG can trace its roots back to August 1863 with the creation of “Friedr.Bayer et comp”, a partnership between businessman Friederich Bayer, and Johann Friederich Weskott, a master dyer. This company would specialize in the manufacture of synthetic dyes and was based in Barmen, now part of Wuppertal in Germany. The company grew quickly, exporting dyes a...

#MedicalMisconduct   #Corruption My third installment on corruption in the pharmaceutical trade - AstraZeneca Ronald Gibson 19 July 2017 To clarify the facts below, only transgressions relating to gross ethical and legal matters are included. Civil cases are not mentioned as the outcomes are mostly based on a jury system and may be open to emotional interpretation. This pharmaceutical giant is based in London, UK, the result of a merger between Zeneca, and Sweden’s Astra AB in 1999. This company has a vast portfolio of products in the cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation fields. AstraZeneca is one of the top 5 pharmaceutical companies in the world, with manufacturing facilities in 19 countries, 9 Research and Development sites, and sales in over 100 countries with total revenue for 2016 stated as $23 Billion. 1. 2003 - Federal officials announced that AstraZeneca had pleaded guilty to criminal and civil charges relat...